These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1752526)

  • 21. Severe idiopathic congenital aplastic anemia: role of hematopoietic growth factors.
    Vermylen C; Cornu G; DeWitte M; Heremans MT; Ninane J; Brichard B
    Bone Marrow Transplant; 1993 Oct; 12(4):413-5. PubMed ID: 8275043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target cells for GM-CSF and kinetics of response.
    Aglietta M; Bussolino F; Piacibello W; Aprá F; Sanavio F; Stacchini A; Monzeglio C; Carnino F; Stern AC; Gavosto F
    Prog Clin Biol Res; 1990; 352():519-30. PubMed ID: 2169636
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytokines in clinical cancer therapy.
    Oettgen HF
    Curr Opin Immunol; 1991 Oct; 3(5):699-705. PubMed ID: 1721823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic growth factors in cancer chemotherapy.
    Lieschke GJ; Foote M; Morstyn G
    Cancer Chemother Biol Response Modif; 1997; 17():363-89. PubMed ID: 9551221
    [No Abstract]   [Full Text] [Related]  

  • 25. Retroviral diseases in hematology.
    Spivak JL; Henry D; Glaspy J
    Rev Invest Clin; 1994 Apr; Suppl():40-6. PubMed ID: 7886307
    [No Abstract]   [Full Text] [Related]  

  • 26. Commentary: hematologic rescue with umbilical cord blood progenitor cells.
    Wagner JE
    Blood Cells; 1994; 20(2-3):293-5. PubMed ID: 7749109
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hematopoiesis regulating factors. Important therapeutic future].
    Parmentier C; Biquard JM
    Rev Prat; 1992 Nov; 42(17):2203-6. PubMed ID: 1290043
    [No Abstract]   [Full Text] [Related]  

  • 28. [Peripheral blood stem cell autografts in pediatric cancer].
    Takaue Y
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2307-12. PubMed ID: 1979725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current status of the clinical application of hematopoietic growth factors in oncology].
    Karthaus M; Ganser A
    Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haematopoietic growth factors in the treatment of therapeutic and accidental irradiation-induced bone marrow aplasia.
    Thierry D; Gourmelon P; Parmentier C; Nénot JC
    Int J Radiat Biol; 1995 Feb; 67(2):103-17. PubMed ID: 7533815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic growth factors in cancer chemotherapy.
    Morstyn G; Foote M; Lieschke GJ
    Cancer Chemother Biol Response Modif; 1996; 16():295-314. PubMed ID: 8639388
    [No Abstract]   [Full Text] [Related]  

  • 32. Hematopoietic growth factors as supportive therapy for cancer- and chemotherapy-induced conditions.
    Symann M
    Curr Opin Oncol; 1991 Aug; 3(4):648-55. PubMed ID: 1932223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1993; 14():207-26. PubMed ID: 8312103
    [No Abstract]   [Full Text] [Related]  

  • 34. Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.
    Stevenson HC; Klein HG
    Prog Clin Biol Res; 1990; 337():559-65. PubMed ID: 2353018
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hemopoietic growth factors: their biological effects and the prospects for their clinical use].
    Dexter TM
    Ontogenez; 1991; 22(4):341-64. PubMed ID: 1945267
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy].
    Gianni AM; Bregni M; Siena S; Tarella C
    Haematologica; 1989 Oct; 74(5 Suppl):511-26. PubMed ID: 2574136
    [No Abstract]   [Full Text] [Related]  

  • 37. Granulocyte-macrophage colony stimulating factor and interleukin 3: target cells and kinetics of response in vivo.
    Aglietta M; Pasquino P; Sanavio F; Stacchini A; Severino A; Fubini L; Morelli S; Volta C; Monteverde A; Piacibello W
    Stem Cells; 1993 Jul; 11 Suppl 2():83-7. PubMed ID: 8401260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of hematological growth factors to enable dose intensification in chemotherapy for soft tissue sarcomas.
    Liem GS; Verweij J
    Stem Cells; 1994 Jul; 12(4):402-8. PubMed ID: 7951007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hematopoietic growth factors].
    Zwierzina H; Hoffmann S; Schmalzl F; Braunsteiner H
    Wien Med Wochenschr; 1991; 141(14):311-20. PubMed ID: 1949830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology].
    Karthaus M; Ganser A
    Zentralbl Gynakol; 1997; 119(12):585-96. PubMed ID: 9483809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.